London 2014 Registration Visa Letters Programme Satellite Meetings Glaucoma Day 2014 Exhibition Hotel Booking Virtual Exhibition Star Alliance
london escrs

Course handouts are now available
Click here


Come to London

video-icon

WATCH to find out why


Site updates:

Programme Updates. Programme Overview and - Video Symposium on Challenging Cases now available.


Posters

Search Abstracts by author or title
(results will display both Free Papers & Poster)

Reduction of IOP in patients after phacoemulsification

Poster Details

First Author: P.Vassileva BULGARIA

Co Author(s):    Y. Kirilova   H. Krusteva           

Abstract Details



Purpose:

To examine the change of IOP after phacoemulsification of all consecutive patients for a period of 4 months.

Setting:

All 192 consecutive patients underwent uneventful phacoemulsification are included in interventional study at University Eye Hospital 'Prof. Pashev'

Methods:

Cataract group consisted of all admitted patients for cataract extraction for period of 4 months. All 192 patients underwent full ophthalmological examination: VA, IOP- preoperative and 3 days, 1, 3 months after operation, depth of anterior chamber, fundus examination. Surgical method is standard phacoemulsification with capsular IOL implantation. Exclusion criteria is complicated surgery.

Results:

184 patients meet all inclusion criteria (excluded 8 patients with PCR during surgery). Exfolative syndrome was observed in 44 patients (24%), 9 (5%) patients with exfoliative glaucoma (compensated with drops).With good control of primary angle open glaucoma and cataract were 8 patients (4%). At the end of observation period average IOP decrease was 12,42%, in patient without glaucoma, while in the group with exfoliative and POAG - with 25,4%. Changes of depth of anterior chamber were registered with IOL master.

Conclusions:

Reduction of IOP post phacoemulsification was significantly greater in patients with glaucoma as compared to patients without glaucoma. Only cataract extraction could be recommended in patients with ocular hypertension and mild glaucoma. FINANCIAL INTEREST: NONE

Back to Poster listing